Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
PJ Richardson, DP Smith, A de Giorgio… - Translational …, 2023 - Springer
Amyotrophic lateral sclerosis (ALS) is a poorly treated multifactorial neurodegenerative
disease associated with multiple cell types and subcellular organelles. As with other …
disease associated with multiple cell types and subcellular organelles. As with other …
Targeting microglial GLP1R in epilepsy: A novel approach to modulate neuroinflammation and neuronal apoptosis
K Zhang, Z Yang, Z Yang, L Du, Y Zhou, S Fu… - European Journal of …, 2024 - Elsevier
Background Epilepsy is a prevalent disorder of the central nervous system. Approximately,
one-third of patients show resistance to pharmacological interventions. The pathogenesis of …
one-third of patients show resistance to pharmacological interventions. The pathogenesis of …
Disease modification upon brief exposure to tofacitinib during chronic epilepsy
OR Hoffman, JL Koehler, JEC Espina, AM Patterson… - bioRxiv, 2023 - biorxiv.org
All current drug treatments for epilepsy, a neurological disorder affecting over 50 million
people (,) merely treat symptoms, and a third of patients do not respond to medication. There …
people (,) merely treat symptoms, and a third of patients do not respond to medication. There …
Bioinformatics analysis reveals multiple functional changes in astrocytes in temporal lobe epilepsy
D Li, Y Wang, Y Guo, W Wang - Brain Research, 2024 - Elsevier
Epilepsy is a prevalent chronic neurological disorder characterized by recurrent seizures
and brain dysfunction. Existing antiepileptic drugs (AEDs) mainly act on neurons and …
and brain dysfunction. Existing antiepileptic drugs (AEDs) mainly act on neurons and …
Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy
Y Yu, FJ Sun - Ibrain, 2024 - Wiley Online Library
Epilepsy is an abnormal neurologic disorder distinguished by the recurrent manifestation of
seizures, and the precise underlying mechanisms for its development and progression …
seizures, and the precise underlying mechanisms for its development and progression …
Epileptic Neurons Know JAK/STAT3
S Kumari, AL Brewster - Epilepsy Currents, 2023 - journals.sagepub.com
Selective Neuronal Knockout of STAT3 Function Inhibits Epilepsy Progression, Improves
Cognition, and Restores Dysregulated Gene Networks in a Temporal Lobe Epilepsy Model …
Cognition, and Restores Dysregulated Gene Networks in a Temporal Lobe Epilepsy Model …
Targeting neuroinflammation in mTORC1 driven brain tumours
D McPhail - 2023 - orca.cardiff.ac.uk
Tuberous sclerosis complex (TSC) is a rare genetic disease that results in the system-wide
growth of benign lesions. TSC patients often present with brain tumours and TSC-associated …
growth of benign lesions. TSC patients often present with brain tumours and TSC-associated …
[引用][C] Blocking ATP signaling and ROS generation preserves neurogenesis and network activity In epileptogenesis In hippocampal organotypic slice cultures.
A Rodríguez Bodero - 2024